Bill Brown, Chairman, and Caroline Stretton, Group Managing Director, of RUA Life Sciences, discuss how the business is proceeding on its FDA regulatory pathway. They also talk about what steps are being put in place to ensure high throughput manufacturing from day one of FDA approval, and the developments in their contract manufacturing business.